Erasca, Inc. (ERAS): Price and Financial Metrics


Erasca, Inc. (ERAS): $4.04

0.13 (+3.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ERAS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ERAS Stock Price Chart Interactive Chart >

Price chart for ERAS

ERAS Price/Volume Stats

Current price $4.04 52-week high $12.80
Prev. close $3.91 52-week low $3.60
Day low $3.90 Volume 1,001,900
Day high $4.11 Avg. volume 1,032,178
50-day MA $5.28 Dividend yield N/A
200-day MA $6.81 Market Cap 494.34M

Erasca, Inc. (ERAS) Company Bio


Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of NSCLC, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. The company was incorporated in 2018 and is headquartered in San Diego, California.


ERAS Latest News Stream


Event/Time News Detail
Loading, please wait...

ERAS Latest Social Stream


Loading social stream, please wait...

View Full ERAS Social Stream

Latest ERAS News From Around the Web

Below are the latest news stories about ERASCA INC that investors may wish to consider to help them evaluate ERAS as an investment opportunity.

The Erasca Inc. (ERAS) had a good session last reading, didn’t it?

A share of Erasca Inc. (NASDAQ:ERAS) closed at $3.89 per share on Monday, up from $3.84 day before. While Erasca Inc. has overperformed by 1.30%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ERAS fell by -65.91%, with highs and lows ranging from $12.80 to $3.60, […]

US Post News | January 24, 2023

Weak Fundamental Momentum Pushes Erasca Inc. (ERAS) Lower

Erasca Inc. (NASDAQ:ERAS) has seen 0.43 million shares traded in the recent trading session. The company, currently valued at $524.58M, closed the recent trade at $3.86 per share which meant it gained $0.02 on the day or 0.52% during that session. The ERAS stock price is -231.61% off its 52-week high price of $12.80 and … Weak Fundamental Momentum Pushes Erasca Inc. (ERAS) Lower Read More »

Marketing Sentinel | January 23, 2023

Erasca Inc. (ERAS) did well last session?

The share price of Erasca Inc. (NASDAQ:ERAS) fell to $4.02 per share on Tuesday from $4.16. While Erasca Inc. has underperformed by -3.37%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ERAS fell by -69.66%, with highs and lows ranging from $13.34 to $3.60, whereas the […]

US Post News | January 18, 2023

Future Outlook And Stock Price Performance For Erasca Inc. (NASDAQ: ERAS)

In the last trading session, 1.13 million shares of the Erasca Inc. (NASDAQ:ERAS) were traded. Most recently the company’s share price was $4.02, and it changed around -$0.14 or -3.37% from the last close, which brings the market valuation of the company to $569.47M. ERAS currently trades at a discount to its 52-week high of … Future Outlook And Stock Price Performance For Erasca Inc. (NASDAQ: ERAS) Read More »

Marketing Sentinel | January 18, 2023

Erasca Inc.’s (NASDAQ: ERAS) Stock Price Continues To Fall

The trading price of Erasca Inc. (NASDAQ:ERAS) closed lower on Friday, January 13, closing at $4.16, -2.80% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $4.105 and $4.38. In examining the 52-week price action we see that the stock hit a 52-week high … Erasca Inc.’s (NASDAQ: ERAS) Stock Price Continues To Fall Read More »

Stocks Register | January 17, 2023

Read More 'ERAS' Stories Here

ERAS Price Returns

1-mo -1.94%
3-mo -49.44%
6-mo -43.89%
1-year -64.09%
3-year N/A
5-year N/A
YTD -6.26%
2022 -72.34%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5972 seconds.